GlassScriptPhysician profile
Angelito Bacay
NPI 1679506836
$1,017.18
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.68 · 2020: $84.33 · 2021: $193 · 2022: $69.17 · 2023: $62.72 · 2024: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529 · Education: $57.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.09 |
| Education | $57.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $184.29 | 2021-2024 | Farxiga, Lokelma |
| Travere Therapeutics, INC. | $145.69 | 2023-2024 | |
| Amgen INC. | $90.80 | 2019-2024 | Krystexxa |
| Lilly USA, LLC | $85.05 | 2023-2024 | Jardiance |
| Fresenius USA Marketing, INC. | $73.17 | 2022-2024 | Velphoro |
| Vifor Pharma, INC. | $68.07 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $65.90 | 2021-2024 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.77 | 2023-2024 | Jardiance |
| Genzyme Corporation | $59.57 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $30.66 | 2024 | Jynarque |
| Akebia Therapeutics INC | $29.16 | 2024 | Vafseo, Auryxia |
| Baxter Healthcare | $23.70 | 2024 | Renal - Pd |
| Amag Pharmaceuticals, INC. | $20.16 | 2020 | |
| Novo Nordisk INC | $18.73 | 2024 | Ozempic |
| Aurinia Pharma U.S., INC. | $17.84 | 2024 | Lupkynis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.98 | 2019 | |
| Opko Pharmaceuticals, LLC | $14.59 | 2022 | |
| Glaxosmithkline, LLC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelito Bacay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.